This shows the importance of pairing any medical plan with exercise and planned nutrition to keep weight off over time
Focusing specifically on Mounjaro, a 2025 study in adults with type 1 diabetes and overweight or obesity found that after 21 months, participants experienced 23% weight loss, sustained improvements in glucose management, and significant improvements in blood pressure, cholesterol, triglycerides , and eGFR (a marker of kidney function)
You will read about the dangers of insulin resistance and excess insulin, and how some of the drugs that mainstream medicine uses to treat diabetes increase insulin levels without regard to ambient glucose levels, potentially contributing to problems in the long term

Food and Drug Administration (2024) Compounding and the FDA: Questions and answers, Food and Drug Administration (2024) Zepbound, DailyMed (2024) FDAs concerns with unapproved GLP-1 drugs used for weight loss, Food and Drug Administration (2024) FDA warns patients and health care professionals not to use compounded drugs from Fullerton Wellness, Food and Drug Administration (2024) An open letter from Eli Lilly and Company regarding certain practices related to Mounjaro and Zepbound, Eli Lilly and Company (2024) Compounding when drugs are on FDAs drug shortages list, Food and Drug Administration (2024) Human drug compounding, Food and Drug Administration (2024) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
A consult makes it possible to build a plan instead of guessing